{"product_id":"endonovo-marketing-mix","title":"Endonovo Therapeutics Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Endonovo Therapeutics' product innovations, pricing approach, distribution channels, and promotional tactics combine to shape its market positioning in our concise 4P's overview. The preview highlights key trends and strategic gaps—ideal for investors, consultants, and students. Purchase the full, editable Marketing Mix Analysis for detailed data, actionable recommendations, and presentation-ready slides to accelerate decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNon-contact EMF therapy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSofPulse delivers non-invasive, non-pharmacological electromagnetic field therapy to reduce pain, inflammation, and edema, enhancing microcirculation and supporting tissue repair without direct contact. Clinical reports indicate about 30% faster recovery and pain reductions around 30% versus baseline, with adverse events under 2%. Its contactless, device-based approach differentiates it from drug and invasive alternatives, centering the product proposition on faster recovery with fewer side effects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-op and wound healing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSofPulse addresses post-operative swelling, pain management and chronic\/acute wound healing with company‑reported results showing ~28% reduction in pain scores and ~30% faster wound closure versus standard care in clinical programs. Indications align with surgical recovery pathways and wound care protocols, yielding fewer complications and improved patient comfort. Reported impacts include ~15% fewer readmissions and estimated hospital savings of $1,000–$1,500 per case, supporting throughput and lower overall care costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical-grade usability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe device emphasizes ease of use for clinicians and patients through straightforward setup and session management workflows that reduce training time and support rapid deployment at bedside and in outpatient clinics.\u003c\/p\u003e\n\u003cp\u003eDesign priorities include safety, repeatability, and consistent dosing parameters to ensure reliable clinical outcomes across repeated sessions.\u003c\/p\u003e\n\u003cp\u003eIts portable form factor enables bedside and ambulatory use, while sterile-compatible packaging and clear instructions support infection-control workflows and seamless integration into clinical protocols.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePipeline indications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEndonovo is advancing indications into ARDS and cytokine storm beyond musculoskeletal and wound care, targeting critical care and respiratory complications; ARDS affects ~190,000 US adults\/year with mortality near 40%, highlighting market opportunity. Evidence-generation (trials, real-world data) will drive label expansion and ICU protocols, strengthening long-term product relevance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePipeline: ARDS, cytokine storm\u003c\/li\u003e\n\u003cli\u003eMarket expansion: critical care\/respiratory\u003c\/li\u003e\n\u003cli\u003eEvidence focus: RCTs and RWD for labeling\u003c\/li\u003e\n\u003cli\u003eStrategic impact: improves long-term relevance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService and support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eService and support includes clinician training, onboarding and technical support, plus data-collection guidance to standardize outcomes and enable reimbursement pathways. Maintenance and regular software updates ensure system reliability; support SLAs target high uptime and rapid issue resolution. Educational materials and coaching improve patient adherence and satisfaction, aligning with the digital therapeutics sector (\u0026gt;5 billion USD market in 2024).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eClinician training\/onboarding\u003c\/li\u003e\n\u003cli\u003eData standardization guidance\u003c\/li\u003e\n\u003cli\u003eMaintenance \u0026amp; software updates\u003c\/li\u003e\n\u003cli\u003ePatient education to boost adherence\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePortable contactless EM therapy: \u003cstrong\u003e~30%\u003c\/strong\u003e pain cut, \u003cstrong\u003e~30%\u003c\/strong\u003e faster closure, saves \u003cstrong\u003e$1-1.5k\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSofPulse is a portable, contactless electromagnetic-field device reducing pain ~28–30% and accelerating wound closure ~30% with adverse events \u0026lt;2%, enabling faster recovery, ~15% fewer readmissions and estimated hospital savings $1,000–$1,500 per case; ICU\/ARDS expansion targets ~190,000 US cases\/yr. Service includes clinician training, data standardization and regular software updates.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePain reduction\u003c\/td\u003e\n\u003ctd\u003e~28–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWound closure\u003c\/td\u003e\n\u003ctd\u003e~30% faster\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdverse events\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReadmission reduction\u003c\/td\u003e\n\u003ctd\u003e~15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital savings\u003c\/td\u003e\n\u003ctd\u003e$1,000–$1,500\/case\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eARDS US cases\u003c\/td\u003e\n\u003ctd\u003e~190,000\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital therapeutics market 2024\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Endonovo Therapeutics’ 4P strategy—highlighting its product focus on bioelectronic and regenerative health solutions, targeted pricing for clinical and research customers, distribution via medical channels and partnerships, and promotion through scientific publications, KOL engagement, conferences, and targeted digital outreach. Ideal for managers and consultants benchmarking marketing positioning and strategy execution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Endonovo Therapeutics’ 4P marketing mix into a concise, plug-and-play snapshot that clarifies product positioning, pricing strategy, channel focus and promotional priorities to relieve decision-making friction. Designed for rapid alignment, it helps leaders and non-marketing stakeholders quickly grasp strategic trade-offs and next-step actions for commercialization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and surgical centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrimary distribution targets perioperative departments, orthopedics, general surgery and pain services across acute care hospitals (6,093 U.S. hospitals per AHA 2023). Integration via hospital purchasing and value analysis committees aligns with formal procurement and clinical-technology assessment processes. Stocking near ORs and PACUs ensures immediate post-procedure availability, and in-servicing across multi-shift staffing accelerates adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWound care clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOutpatient wound centers and home-health partners support Endonovo’s ongoing therapy for roughly 6.7 million US chronic wound patients, a market driving about $28 billion in Medicare-related annual spend. Clinic inventory and scheduling align to weekly care plans (typical 1 visit\/week), coordination with podiatry and vascular practices expands referral pipelines, and telehealth follow-ups boost adherence by ~15% between visits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributor partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegional medical device distributors and DME channels expand Endonovo Therapeutics coverage through tiered agreements that include training, demo units, and clear service-level expectations. CRM-enabled lead sharing implemented in 2024 accelerates conversion by improving follow-up and tracking across partners. Comprehensive compliance and quality documentation streamline onboarding and reduce administrative delays for hospitals and clinics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-provider sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEndonovo's internal sales team targets IDNs, VA\/DoD and large group practices, using account-based outreach to KOLs and key decision makers. Pilot device placements precede broader rollouts. VA operates ~1,300 facilities and DoD ~200 medical centers; GPOs represent ~90% of US hospitals and guide contracting.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTarget: IDNs, VA\/DoD, large groups\u003c\/li\u003e\n\u003cli\u003eStrategy: account-based, KOL-focused\u003c\/li\u003e\n\u003cli\u003eExecution: pilots then rollouts\u003c\/li\u003e\n\u003cli\u003eContracts: align with GPOs (~90% hospital coverage)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and rentals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eE-commerce and rentals through Endonovo's online portal streamline reorders, rentals, and service requests while supporting patient-specific supervised home-use programs where regulations permit, backed by integrated logistics for rapid shipping and returns processing.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOnline reorders\/rentals\u003c\/li\u003e\n\u003cli\u003eSupervised home-use programs\u003c\/li\u003e\n\u003cli\u003eRapid shipping \u0026amp; returns\u003c\/li\u003e\n\u003cli\u003eInventory visibility to cut stockouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcute care and wound centers: 6.7M patients driving a $28B Medicare market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePlace focuses on acute care (6,093 US hospitals per AHA 2023) and perioperative\/PACU stocking for immediate use, plus outpatient wound centers serving ~6.7M chronic-wound patients driving ~$28B Medicare spend. Distribution via regional distributors, GPOs (~90% hospital coverage), IDNs, VA (~1,300) and DoD (~200) with CRM (2024) and telehealth (+15% adherence) support e-commerce\/rental fulfillment.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS hospitals\u003c\/td\u003e\n\u003ctd\u003e6,093 (AHA 2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChronic wound pts\u003c\/td\u003e\n\u003ctd\u003e6.7M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare spend\u003c\/td\u003e\n\u003ctd\u003e$28B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO coverage\u003c\/td\u003e\n\u003ctd\u003e~90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVA \/ DoD\u003c\/td\u003e\n\u003ctd\u003e~1,300 \/ ~200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCRM launch\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelehealth impact\u003c\/td\u003e\n\u003ctd\u003e+15% adherence\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eEndonovo Therapeutics 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Endonovo Therapeutics 4P's Marketing Mix Analysis you’ll receive instantly after purchase—no surprises. It covers Product, Price, Place and Promotion with actionable insights tailored to Endonovo’s positioning. The file is complete, editable and ready for immediate use. Buy with confidence; this is the exact document delivered at checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164597268857,"sku":"endonovo-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/endonovo-marketing-mix.png?v=1762737279","url":"https:\/\/portersfiveforce.com\/products\/endonovo-marketing-mix","provider":"Porter's Five Forces","version":"1.0","type":"link"}